Artikler med krav om offentlig adgang - Khalid Al-RasadiFå flere oplysninger
Ikke tilgængelige nogen steder: 2
Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action
KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ...
JAMA cardiology 5 (2), 217-229, 2020
Krav: UK Medical Research Council
Potential benefits of phytochemicals for abdominal aortic aneurysm
A Hosseini, PE Penson, AFG Cicero, J Golledge, K Al-Rasadi, ...
Current medicinal chemistry 28 (41), 8595-8607, 2021
Krav: National Health and Medical Research Council, Australia
Tilgængelige et sted: 14
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe …
RD Santos, SS Gidding, RA Hegele, MA Cuchel, PJ Barter, GF Watts, ...
The lancet Diabetes & endocrinology 4 (10), 850-861, 2016
Krav: US National Institutes of Health, Canadian Institutes of Health Research …
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
The Lancet 398 (10312), 1713-1725, 2021
Krav: Canadian Institutes of Health Research, National Institute for Health …
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
GF Watts, SS Gidding, RA Hegele, FJ Raal, AC Sturm, LK Jones, ...
Nature Reviews Cardiology 20 (12), 845-869, 2023
Krav: National Health and Medical Research Council, Australia, Medical Research …
Vascular calcifications in homozygote familial hypercholesterolemia
Z Awan, K Alrasadi, GA Francis, RA Hegele, R McPherson, J Frohlich, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (4), 777-785, 2008
Krav: Canadian Institutes of Health Research
The relationship between COVID-19 and hypothalamic–pituitary–adrenal axis: a large spectrum from glucocorticoid insufficiency to excess—the CAPISCO International Expert Panel
M Jensterle, R Herman, A Janež, WA Mahmeed, K Al-Rasadi, K Al-Alawi, ...
International Journal of Molecular Sciences 23 (13), 7326, 2022
Krav: Slovenian Research Agency
Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry
MA Bamimore, A Zaid, Y Banerjee, A Al-Sarraf, M Abifadel, NG Seidah, ...
Journal of clinical lipidology 9 (2), 187-194, 2015
Krav: Canadian Institutes of Health Research
Absence of coronary artery calcification in middle-aged familial hypercholesterolemia patients without atherosclerotic cardiovascular disease
R Mszar, GR Grandhi, J Valero-Elizondo, SS Virani, R Blankstein, ...
Cardiovascular Imaging 13 (4), 1090-1092, 2020
Krav: US National Institutes of Health, US Department of Veterans Affairs …
Anti-fibrotic effects of curcumin and some of its analogues in the heart
AM Gorabi, S Hajighasemi, N Kiaie, GMC Rosano, T Sathyapalan, ...
Heart Failure Reviews 25, 731-743, 2020
Krav: UK Medical Research Council
Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release …
K Alrasadi, Z Awan, K Alwaili, I Ruel, A Hafiane, L Krimbou, J Genest
The American journal of cardiology 102 (10), 1341-1347, 2008
Krav: US National Institutes of Health, Canadian Institutes of Health Research
Effect of ABCA1 mutations on risk for myocardial infarction
I Iatan, K Alrasadi, I Ruel, K Alwaili, J Genest
Current atherosclerosis reports 10 (5), 413-426, 2008
Krav: Canadian Institutes of Health Research
A new look at novel cardiovascular risk biomarkers: the role of atherogenic lipoproteins and innovative antidiabetic therapies
J Vekic, A Zeljkovic, K Al Rasadi, M Cesur, J Silva-Nunes, AP Stoian, ...
Metabolites 12 (2), 108, 2022
Krav: Ministry of Education, Science and Technological Development of the Republic …
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East
N Al Sayed, K Al Waili, F Alawadi, S Al-Ghamdi, W Al Mahmeed, ...
International journal of cardiology 225, 268-283, 2016
Krav: National Health and Medical Research Council, Australia
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross …
A Elshorbagy, ARM Lyons, AJ Vallejo-Vaz, CAT Stevens, KI Dharmayat, ...
The Lancet Diabetes & Endocrinology 12 (11), 811-823, 2024
Krav: National Institute for Health Research, UK
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
A Elshorbagy, AJ Vallejo-Vaz, F Barkas, ARM Lyons, CAT Stevens, ...
European Heart Journal, ehae791, 2025
Krav: National Institute for Health Research, UK
Oplysninger om publikation og økonomisk støtte registreres automatisk af et computerprogram